Soon-Hyun Ahn Selected Research

Soon-Hyun Ahn Research Topics

18	Neoplasms (Cancer) 05/2021 - 02/2008
10	Squamous Cell Carcinoma of Head and Neck 04/2022 - 10/2015
9	Papillary Thyroid Cancer 05/2020 - 08/2008
8	Thyroid Neoplasms (Thyroid Cancer) 06/2019 - 08/2008
5	Neoplasm Metastasis (Metastasis) 04/2022 - 02/2008
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 04/2011
5	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 02/2012
2	Tongue Neoplasms (Tongue Neoplasm) 05/2020 - 01/2017
2	Hypopharyngeal Neoplasms 02/2020 - 01/2019
2	Carcinogenesis 10/2016 - 02/2013
2	Thyroiditis 01/2015 - 01/2011
2	Lymphatic Metastasis 04/2014 - 02/2008
1	Oropharyngeal Neoplasms 04/2022
1	Infarction (Infarctions) 01/2022
1	Myocardial Infarction 01/2022
1	Adenoid Cystic Carcinoma (Cylindroma) 01/2022
1	Extranodal Extension 06/2021
1	Margins of Excision 06/2021
1	Parotid Neoplasms 06/2021
1	Carcinoma (Carcinomatosis) 05/2020
1	Deglutition Disorders (Dysphagia) 02/2020
1	Aspiration Pneumonia 02/2020
1	Laryngeal Neoplasms (Laryngeal Cancer) 02/2020
1	Papillomavirus Infections 01/2020
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 12/2019
1	Pain (Aches) 10/2019
1	Hematoma 10/2019
1	Postoperative Pain 10/2019
1	Anorexia 01/2019
1	Neutropenia 01/2019
1	Cutaneous Fistula 10/2018
1	Abscess 10/2018
1	Fistula 10/2018
1	Lymphadenitis (Adenitis) 10/2018
1	Pharyngitis (Sore Throat) 02/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2016
1	Hypothyroidism 01/2015
1	Papillary Thyroid Microcarcinoma 08/2014
1	Polyps 05/2014

3	Biomarkers (Surrogate Marker)IBA 04/2020 - 08/2019
2	Complementary DNA (cDNA)IBA 04/2020 - 10/2018
2	CD40 Ligand (CD40L)IBA 12/2019 - 10/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 10/2015
2	Proteins (Proteins, Gene)FDA Link 10/2018 - 03/2012
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2016 - 01/2011
1	Dialysis SolutionsIBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	dimemorfan (AT 17)IBA 05/2021
1	AZD 8931IBA 04/2020
1	Estrogen ReceptorsIBA 01/2020
1	CytokinesIBA 12/2019
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 10/2019
1	KetorolacIBA 10/2019
1	InterferonsIBA 08/2019
1	genexol-PMIBA 01/2019
1	B7-H1 AntigenIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 09/2018
1	tanespimycin (17AAG)IBA 01/2017
1	Celecoxib (Celebrex)FDA Link 01/2017
1	Fluorouracil (Carac)FDA LinkGeneric 01/2017
1	plerixafor FDA Link 10/2016
1	Thyroglobulin FDA Link 01/2016
1	AntibodiesIBA 01/2016
1	IodineIBA 01/2016
1	Cetuximab (Erbitux)FDA Link 10/2015
1	Docetaxel (Taxotere)FDA Link 10/2015
1	alpha Subunit Hypoxia-Inducible Factor 1IBA 09/2015
1	temsirolimus FDA Link 04/2015
1	LAQ824IBA 04/2015
1	EchinomycinIBA 04/2015
1	Vorinostat FDA Link 04/2015
1	Indicators and Reagents (Reagents)IBA 02/2015
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2015
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 08/2014
1	Valine (L-Valine)FDA Link 07/2014
1	Glutamic Acid (Glutamate)FDA Link 07/2014
1	CalciumIBA 05/2014

7	Radiotherapy 04/2022 - 02/2012
7	Therapeutics 05/2021 - 09/2011
6	Neck Dissection (Radical Neck Dissection) 05/2020 - 02/2012
5	Chemoradiotherapy 04/2022 - 02/2012
4	Thyroidectomy 10/2019 - 01/2011
3	Induction Chemotherapy 01/2019 - 10/2015
2	Free Tissue Flaps 01/2022 - 03/2013
2	Tracheostomy 02/2020 - 01/2004
2	Conservative Treatment 10/2018 - 05/2014
2	Tonsillectomy 01/2016 - 08/2010
2	General Anesthesia 05/2012 - 08/2010
2	Oral Administration 04/2009 - 08/2008
1	Aftercare (After-Treatment) 01/2022
1	Metastasectomy 01/2022
1	Re-Irradiation 12/2021
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 12/2021
1	Glossectomy 05/2020
1	Combined Modality Therapy 02/2020
1	Duration of Therapy 10/2018
1	Laryngoscopes 02/2017
1	Intraperitoneal Injections 10/2016
1	Adjuvant Chemotherapy 04/2015
1	Drug Therapy (Chemotherapy) 04/2015